EUVIMEDEUVIMED entdecken
Crossref

Generation of human-induced pluripotent stem cells from a patient with Beckwith–Wiedemann syndrome

Mei Tang, Jiafan Lei, Congwen Shao, Wenyan Zhou, Min Xiong, Min Huang, Chunyan Huang, Fei Wang, Jun Liu, Jun Li, Xueqing Xu

Human Cell · 2025

DOI: 10.1007/s13577-025-01247-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Cell, 2025. Verfasst von Mei Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision Medicine, Shenzhen Hospital, Southern Medical University, Shenzhen, 518100, People's Republic of China. Hauptthemen laut MEDLINE: Beckwith-Wiedemann Syndrome, Induced Pluripotent Stem Cells. Die Arbeit nennt 27 Literaturangaben. Gefördert von: the Medical Science and Technology Foundation of Guangdong Province, the Bao'an District Medical and Health Research Project, Guangdong Provincial Clinical Research Center for Laboratory Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beckwith-Wiedemann syndrome (BWS) is a human genomic imprinting disorder mainly caused by an imprinting abnormality in the chromosome 11p15.5 region. It is rare and sporadic with unclear etiology and pathogenesis. We identified a family with a clustering of BWS cases arising from methylation abnormality of IC1 region. An induced pluripotent stem-cell line (BWS iPSC) was generated from peripheral blood mononuclear cells (PBMCs) of one affected family member using a non-integrating reprogramming method. This cell line could be further differentiated into multiple lineages, enabling us to determine the relationship of the expression of abnormal imprinting genes in BWS to cellular phenotypes, thus elucidating the pathogenic mechanisms of BWS. In future, the multi-lineage cells can be used to test various innovative therapies, providing conceptual validation for the treatment of BWS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Beckwith-Wiedemann SyndromeInduced Pluripotent Stem CellsHumansGenomic ImprintingCell DifferentiationDNA MethylationLeukocytes, MononuclearMaleChromosomes, Human, Pair 11FemaleCells, CulturedCell LineCellular Reprogramming

Stichwörter der Autor:innen

Beckwith–Wiedemann syndromeEpigenetic modificationImprinting disturbanceRare diseaseiPSC

Autor:innen und Institutionen

  • Department of Precision Medicine, Shenzhen Hospital, Southern Medical University, Shenzhen, 518100, People's Republic of China.
  • Guangdong Provincial Clinical Research Center for Laboratory Medicine, Guangzhou, 510280, People's Republic of China.
  • Shenzhen Hospital, Southern Medical University, Shenzhen, 518100, People's Republic of China.
  • Department of Precision Medicine, Shenzhen Hospital, Southern Medical University, Shenzhen, 518100, People's Republic of China. chubuyi@qq.com.
  • Guangdong Provincial Clinical Research Center for Laboratory Medicine, Guangzhou, 510280, People's Republic of China. chubuyi@qq.com.

Förderung

  • the Medical Science and Technology Foundation of Guangdong Province
  • the Bao'an District Medical and Health Research Project
  • Guangdong Provincial Clinical Research Center for Laboratory Medicine

Zitieren

APA

Tang, M., Lei, J., Shao, C., Zhou, W., Xiong, M., Huang, M., Huang, C., Wang, F., Liu, J., Li, J., & Xu, X. (2025). Generation of human-induced pluripotent stem cells from a patient with Beckwith–Wiedemann syndrome. Human Cell. https://doi.org/10.1007/s13577-025-01247-2

Vancouver

Tang M, Lei J, Shao C, Zhou W, Xiong M, Huang M, et al. Generation of human-induced pluripotent stem cells from a patient with Beckwith–Wiedemann syndrome. Human Cell. 2025. doi:10.1007/s13577-025-01247-2

BibTeX
@article{Tang2025,
  author = {Tang, Mei and Lei, Jiafan and Shao, Congwen and Zhou, Wenyan and Xiong, Min and Huang, Min and Huang, Chunyan and Wang, Fei and Liu, Jun and Li, Jun and Xu, Xueqing},
  title = {Generation of human-induced pluripotent stem cells from a patient with Beckwith–Wiedemann syndrome},
  journal = {Human Cell},
  year = {2025},
  doi = {10.1007/s13577-025-01247-2}
}
Kostenlos starten →